Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Family Presence in the Intensive Care Unit: Impact of an Expanded Visiting Policy on Healthcare Professionals' Attitudes and Experiences During the Transition to a New Unit With Individual Patient Rooms

NCT07887009 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07887009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Family Presence in the Intensive Care Unit: Impact of an Expanded Visiting Policy on Healthcare Professionals' Attitudes and Experiences During the Transition to a New Unit With Individual Patient Rooms
Lead sponsor
Universitair Ziekenhuis Brussel
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 29, 2026
Completion date
December 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adaptation to extended family presence in the icu, association between stress sensitivity and attitudes toward family presence, icu staff attitudes toward family presence, icu staff experience of family presence

Arms

As registered; 1 arm.

  • questionnaire on attitudes and validation of family participation on ICU Otherquestionnaire

    questionnaire

Primary endpoints

Registered primary outcome measures; 2 primary.

  • Changes from baseline in healthcare providers'attitudes and perceptions regarding family presence in the adult ICU (Intensive Care Unit) Baseline (T0) assessed once before implementation of the extended visiting policy. Follow- up (T2) assessed once approximately 6 months after implementation of the extended visiting policy.

    The change in healthcare providers' attitudes and perceptions is measured using the BAVIQ score prior to the introduction of the more flexible visitation policy (baseline) and six months after implementation (Follow-up) . The primary out is the change in the BAVIQ score between the baseline measurements and Follow-up.

    No predifined threshold is used; scores are analysed as continuous measures.

    Time points:

    T0 = baseline time point, before implementation of the extended visiting policy.

    T1 = implementation time point, during the early implementation period of the extended visiting policy.

    T2 = follow-up time point, approximately 6 months after implementation of the extended visiting policy.

  • association between individual vulnerability to stress and overload and attitudes and perceptions regarding family presence. Baseline (T0) assessed once before implementation of the extended visiting policy.

    The susceptibility to individual vulnerability to stress and overload is measured using the IPIP-NEO facet scales for Anxiety and Vulnerability at baseline. The outcome measures are the IPIP-NEO Anxiety and Vulnerability facet scores, their association with the BAVIQ score at baseline, and their association with the change in the BAVIQ score between baseline and follow up.

    Time points:

    T0 = baseline time point, before implementation of the extended visiting policy.

    T1 = implementation time point, during the early implementation period of the extended visiting policy.

    T2 = follow-up time point, approximately 6 months after implementation of the extended visiting policy.

Papers

PubMed papers this trial cites; 6 papers, results papers first, then newest first.

+1 more paper

Source: PubMed, NCBI/NLM (public domain).

Lead sponsor's other trials

Universitair Ziekenhuis Brussel, most recent start first.